SEHK:2652Pharmaceuticals
CF PharmTech (SEHK:2652) Stock Pressured By Widening Losses And Thin Profit Clarity
CF PharmTech stock has already been under pressure, with the share price down about 31% over the past three months, and today’s earnings give investors a clear reason why. The market is reacting to a story that is not about revenue size; it is about profits that have slipped into a loss again.
The headline for this half is simple. CF PharmTech generated revenue of C¥210.154 million but reported a net loss of C¥10.506 million and a loss per share. That profit squeeze lands on a stock already...